A consortium including Continental Grain, Bunge and Tekfen has pushed the crop nutrition product developer's total funding to more than $186m.
US-based crop nutrition technology developer Pivot Bio completed a $100m series C round yesterday featuring industrial conglomerate Tekfen and commodity trading firms Bunge and Continental Grain.
Energy technology investment fund Breakthrough Energy Ventures (BEV) and Singaporean state-owned firm Temasek co-led the round, which included DCVC, Prelude Ventures, Spruce Capital Partners, Codon Capital, Pavilion Capital and private investors Alan Cohen and Roger Underwood.
Tefken and Bunge participated in the round through corporate venturing subsidiaries Tekfen Ventures and Bunge Ventures, and it…
